Summary Q4 2020 is shaping up to look a lot like Q4 2018. The Fed spiked punch bowl is almost empty. You should be killing what’s left of your zombie stocks now. 2021 will be either a trickle down stagflationary depression or a growth from the middle recovery. The stock market will become more bifurcated in either situation with the ends of our barbell profiting as most other stocks suffer. […]
AbbVie is one of the leading pharma companies in the world. It’s growth however is in question as Humira slowly get biosimilar competition.